Latest SEC Filings

Polomar Health Services, Inc.Polomar Health Services Reports Revenue Surge to $1.53 Million in Latest Quarter

VirnetX Holding CorpVirnetX Reports No Revenue and Increased Net Losses in Q2 2026

SC II Acquisition Corp.SC II Acquisition Corp. Reports Net Income of $1.02M for Quarter Ending June 30, 2026

CERO THERAPEUTICS HOLDINGS, INC.Cero Therapeutics Reports $1.03 Million Net Loss, Advances CER-1236 in Clinical Trials

Infinite Eagle Acquisition Corp.Infinite Eagle Acquisition Corp. Reports Q2 2026 Financial Results with $2.96M Net Income

SOUNDTHINKING, INC.SoundThinking Reports 8% Revenue Decline and Increased Net Loss in Q2 2026

Globa Terra Acquisition CorpGloba Terra Acquisition Corporation Reports $1.35 Million Net Income for Q2 2026

Translational Development Acquisition Corp.Translational Development Acquisition Corp. Reports Q2 2026 Financial Results and Strategic Developments

Drugs Made In America Acquisition Corp.Drugs Made In America Acquisition Corp. Reports Q2 2026 Financial Results and Merger Plans

Edgemode, Inc.Edgemode Reports $3.1 Million Net Loss in Q2 2026, Shifts Focus to High-Performance Computing

QDM International Inc.QDM International Inc. Reports 133.4% Revenue Growth to $8.39 Million in Latest Quarter

Viking Acquisition Corp. IIViking Acquisition Corp. II Reports $928K Net Loss and Completes $230M IPO

Abpro Holdings, Inc.Abpro Holdings Reports Improved Net Loss of $940,000 in Q2 2026

Quince Therapeutics, Inc.Quince Therapeutics Reports $75.5 Million Net Loss and Acquires Orphai Therapeutics

Cantor Equity Partners V, Inc.Cantor Equity Partners V Reports $2.17 Million Net Income for Q2 2026

Digimarc CorpDigimarc Reports 8% Revenue Decline and Increased Operating Loss in Q2 2026

Cantor Equity Partners I, Inc.Cantor Equity Partners Reports $6.5 Million Net Income for Q2 2026, Plans Business Combination with BSTR Holdings

Cantor Equity Partners VII, Inc.Cantor Equity Partners VII Reports Net Income of $134,000 in Q2 2026 Following IPO

ENDRA Life Sciences Inc.ENDRA Life Sciences Reports Improved Financial Performance in Q2 2026

SmartKem, Inc.SmartKem Reports No Revenue and Increased Losses in Latest 10-Q Filing

Cantor Equity Partners IV, Inc.Cantor Equity Partners IV Reports $3.9M Net Income for Q2 2026, Up from Loss in 2025

Sphere 3D Corp.Sphere 3D Corp. Reports Revenue Decline and Increased Expenses in Q2 2026

Evofem Biosciences, Inc.Evofem Biosciences Reports 45% Decline in Q2 2026 Net Sales, Faces Financial Challenges

Nomadar Corp.Nomadar Corp. Reports 115% Revenue Increase but Faces $2.03 Million Net Loss in First Half of 2026

Vireo Growth Inc.Vireo Growth Inc. Reports 335% Revenue Increase to $209.3 Million in Latest Quarter